I think Takeda used MUFG when they swallowed Shire, although compared to the $62Bn Shire acquisition, Prana would be barely a blip on the radar. The market PBT434 is going after is big even by pharma standards. Morgan Stanley was advising Shire. Just saying. Is it possible the price was hammered down for a reason?
Ann: Ceasing to be a substantial holder from MUFG, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.6¢ |
Change
0.001(6.67%) |
Mkt cap ! $147.3M | |||
| Open | High | Low | Value | Volume |
| 1.5¢ | 1.7¢ | 1.5¢ | $770.2K | 49.71M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 2038332 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 349000 | 2 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| ATH (ASX) Chart |